Medifast, Inc. (MED)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
210.97-9.26 (-4.20%)
At close: 1:00PM EST
216.22 +5.25 (+2.49%)
After hours: 03:55PM EST
After hours: 03:55PM EST
| Previous Close | 220.23 |
| Open | 214.09 |
| Bid | 210.98 x 900 |
| Ask | 216.22 x 900 |
| Day's Range | 207.88 - 216.56 |
| 52 Week Range | 183.46 - 336.99 |
| Volume | 72,693 |
| Avg. Volume | 131,374 |
| Market Cap | 2.451B |
| Beta (5Y Monthly) | 1.44 |
| PE Ratio (TTM) | 15.82 |
| EPS (TTM) | 13.34 |
| Earnings Date | Feb. 23, 2022 - Feb. 28, 2022 |
| Forward Dividend & Yield | 5.68 (2.58%) |
| Ex-Dividend Date | Sep. 20, 2021 |
| 1y Target Est | 348.00 |
- Zacks
Should Value Investors Pick Medifast (MED) Stock Now?
Is Medifast (MED) a great pick from the value investor's perspective right now? Read on to know more.
- Yahoo Finance Video
Medifast CEO: 'We changed our business model to be focused on coaches'
Medifast CEO Dan Chard discusses how his company has outpaced 2021 and Q3 estimates, as it has modified its healthy living service model to focus more on direct-to-consumer.
- Motley Fool
Medifast Inc (MED) Q3 2021 Earnings Call Transcript
At this time, I would like to turn the conference over to Reed Anderson with ICR. On the call with me today are Dan Chard, Chairman and Chief Executive Officer; and Jim Maloney, Chief Financial Officer.
